Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipidware is a Malaysian biotechnology company specializing in lipid technology and nanotechnology for skincare and cosmeceutical applications. Founded in 2016 as a spin-off from Universiti Putra Malaysia (UPM), the company developed the REMDII brand, which features a "smart moisturizer" formulation designed to penetrate deep skin layers. Their flagship product, REMDII Sensitive, is a non-steroid cream that has undergone Phase II clinical trials for the treatment of atopic dermatitis in children. Lipidware focuses on natural functional ingredients and proprietary production techniques to provide effective alternatives to conventional steroid treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipidware.